XML 20 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 1,703.3 $ 1,166.1
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 1,808.1 1,644.0
Share based compensation 135.7 159.7
Expense related to the unwind of inventory fair value adjustments 40.9 688.7
Change in deferred taxes 14.2 (392.4)
Change in fair value of contingent consideration 100.4 144.3
Impairment of PP&E and intangible assets 169.5 167.6
Gain on sale of Oncology franchise (267.2) 0.0
Other, net (7.2) 99.2
Changes in operating assets and liabilities:    
Increase in accounts receivable (362.0) (301.5)
(Decrease)/increase in sales deduction accrual (22.6) 94.0
Increase in inventory (305.4) (245.2)
Decrease in prepayments and other assets 44.6 70.4
Decrease in accounts payable and other liabilities (244.8) (557.8)
Net cash provided by operating activities 2,807.5 2,737.1
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from sale of Oncology franchise 2,412.2 0.0
Purchases of PP&E (564.6) (565.5)
Acquisition of business, net of cash acquired (104.7) 0.0
Proceeds from sale of investments 31.8 48.1
Other, net (97.9) 34.8
Net cash provided by/(used in) investing activities 1,676.8 (482.6)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from revolving line of credit, long term and short term borrowings 3,735.3 3,261.6
Repayment of revolving line of credit, long term and short term borrowings (7,969.0) (5,664.5)
Payment of contingent consideration (396.0) 0.0
Payment of dividend (276.6) (234.7)
Proceeds from issuance of stock for share-based compensation arrangements 180.8 92.2
Other, net (25.6) (26.2)
Net cash used in financing activities (4,751.1) (2,571.6)
Effect of foreign exchange rate changes on cash and cash equivalents (11.9) 6.2
Net decrease in cash, cash equivalents, and restricted cash (278.7) (310.9)
Cash, cash equivalents, and restricted cash at beginning of period 511.8 554.5
Cash, cash equivalents, and restricted cash at end of period 233.1 243.6
Supplemental information:    
Interest paid 427.1 434.9
Income taxes paid, net 528.4 308.0
Cash, cash equivalents, and restricted cash at end of period $ 511.8 $ 554.5